70: Data as Strategic Asset: Executive Analytics in the age of Pharma 4.0
In the era of Pharma 4.0, data isn’t just a byproduct—it’s the currency of innovation. Yet, most pharma companies remain “data-rich but information-poor,” with 70% lacking formal governance and 80% of scientific data lost within two decades. This episode reveals how leading organizations are breaking down silos, leveraging AI-driven analytics, and transforming data into measurable […]